Gland Pharma

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE068V01023
  • NSEID: GLAND
  • BSEID: 543245
INR
3,331.35
40.3 (1.22%)
BSENSE

Nov 20

BSE+NSE Vol: 3.17 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'26
Jun'26
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Net Sales
1,833.59
1,800.27
1,742.79
1,695.36
1,486.88
1,505.62
1,424.91
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,833.59
1,800.27
1,742.79
1,695.36
1,486.88
1,505.62
1,424.91
Raw Material Cost
640.75
588.20
594.07
529.89
558.43
557.36
587.57
Purchase of Finished goods
3.14
1.95
2.28
1.50
1.94
0.88
3.10
(Increase) / Decrease In Stocks
25.93
34.18
-5.02
45.26
-6.56
-37.11
-102.71
Employee Cost
411.51
444.00
411.57
424.20
385.03
408.04
373.37
Power Cost
59.94
55.88
53.02
54.01
50.17
45.66
52.60
Manufacturing Expenses
-0.01
0.00
0.00
0.00
0.00
0.00
-0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
208.29
186.69
173.85
205.62
183.98
163.03
163.48
Total Expenditure (Excl Depreciation)
1,349.55
1,310.90
1,229.77
1,260.48
1,172.99
1,137.86
1,077.40
Operating Profit (PBDIT) excl Other Income
484.04
489.37
513.02
434.88
313.89
367.76
347.51
Other Income
69.05
61.23
111.47
63.17
84.16
57.53
44.03
Operating Profit (PBDIT)
553.09
550.60
624.49
498.05
398.05
425.29
391.54
Interest
7.14
4.36
10.03
3.93
7.82
11.50
7.45
Exceptional Items
0.00
0.00
0.00
-24.35
0.00
0.00
0.00
Gross Profit (PBDT)
545.95
546.24
614.46
469.77
390.23
413.79
384.09
Depreciation
115.01
111.26
108.66
107.65
106.31
101.05
95.76
Profit Before Tax
430.94
434.98
505.80
362.13
283.92
312.74
288.33
Tax
140.19
118.02
139.12
100.65
100.23
97.26
101.79
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
290.76
316.96
366.68
261.48
183.68
215.48
186.54
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
290.76
316.96
366.68
261.48
183.68
215.48
186.54
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
290.76
316.96
366.68
261.48
183.68
215.48
186.54
Equity Capital
16.50
16.50
16.48
16.48
16.48
16.48
16.48
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
17.62
19.21
22.25
15.87
11.15
13.08
11.32
Diluted Earnings per share
17.62
19.22
22.23
15.87
11.15
13.08
11.32
Operating Profit Margin (Excl OI)
26.4%
27.18%
29.44%
25.65%
21.11%
24.43%
24.39%
Gross Profit Margin
29.77%
30.34%
35.26%
27.71%
26.24%
27.48%
26.96%
PAT Margin
15.86%
17.61%
21.04%
15.42%
12.35%
14.31%
13.09%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Sep 2026 is 1.85% vs 3.30% in Jun 2026

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Sep 2026 is -8.27% vs -13.56% in Jun 2026

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Sep 2026 is -1.09% vs -4.61% in Jun 2026

stock-summary

Interest

QoQ Growth in quarter ended Sep 2026 is 63.76% vs -56.53% in Jun 2026

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

Compare Quarterly Results Of Gland Pharma With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
1,833.59
0
1,833.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,833.59
0
1,833.59
Raw Material Cost
640.75
0
640.75
Purchase of Finished goods
3.14
0
3.14
(Increase) / Decrease In Stocks
25.93
0
25.93
Employee Cost
411.51
0
411.51
Power Cost
59.94
0
59.94
Manufacturing Expenses
-0.01
0
-0.01
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
208.29
0.00
208.29
Total Expenditure (Excl Depreciation)
1,349.55
0
1,349.55
Operating Profit (PBDIT) excl Other Income
484.04
0.00
484.04
Other Income
69.05
0
69.05
Operating Profit (PBDIT)
553.09
0
553.09
Interest
7.14
0
7.14
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
545.95
0
545.95
Depreciation
115.01
0
115.01
Profit Before Tax
430.94
0
430.94
Tax
140.19
0
140.19
Provisions and contingencies
0.00
0
0.00
Profit After Tax
290.76
0
290.76
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
290.76
0
290.76
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
290.76
0
290.76
Equity Capital
16.50
0
16.50
Face Value
1.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
17.62
0
17.62
Diluted Earnings per share
17.62
0
17.62
Operating Profit Margin (Excl OI)
26.40%
0%
0.00
26.40%
Gross Profit Margin
29.77%
0%
0.00
29.77%
PAT Margin
15.86%
0%
0.00
15.86%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 1,833.59 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 1.85% vs 3.30% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 23.32% vs 5.77% in Sep 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 290.76 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -8.27% vs -13.56% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 58.30% vs 12.32% in Sep 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 484.04 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is -1.09% vs -4.61% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is 54.21% vs 5.67% in Sep 2025

Quarterly - Interest
Interest 7.14 Cr
in Sep 2026

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2026 is 63.76% vs -56.53% in Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 is -8.70% vs 27.99% in Sep 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 26.40%
in Sep 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2026 has fallen from Jun 2026

stock-summary

YoY Growth in quarter ended Sep 2026 has improved from Sep 2025